Drug Type Fab fragment |
Synonyms GPVI-antibody Fab, COR 5, COR5 |
Target |
Mechanism GPVI inhibitors(Platelet membrane glycoprotein VI inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Disease | Preclinical | DE | 19 Dec 2023 | |
Stroke | Preclinical | DE | 19 Dec 2023 |